Skip to main content
. 2024 Nov 6;14:26985. doi: 10.1038/s41598-024-75789-0

Table 1.

Characteristics of the animals and effects of CXCR7 mAb treatment.

Control Control + CXCR7 DOCA-UNX DOCA-UNX + CXCR7
Group size 7 7 6 6
Body weight (BW) (g) 27.9 ± 0.8 28.8 ± 0.6 26.5 ± 0.9 26.3 ± 0.9
Heart weight (HW) (mg) 144 ± 8 153 ± 9 186 ± 14* 175 ± 7
HW/BW (mg/g) 5.2 ± 0.2 5.3 ± 0.2 7.07 ± 0.7* 6.7 ± 0.4
Kidney weight (KW) (mg) 306 ± 24 310 ± 15 582 ± 35* 489 ± 30*
KW/BW (mg/g) 10.9 ± 0.6 10.7 ± 0.4 21.9 ± 1.0* 16.3 ± 3.0*
Lung weight (LW) (mg) 168 ± 8 188 ± 7 198 ± 22 177 ± 7
LW/BW (mg/g) 6.0 ± 0.2 6.5 ± 0.2 7.6 ± 1.0 6.7 ± 0.2
Tibia length (TL) (mm) 17.4 ± 0.1 17.4 ± 0.1 16.9 ± 0.1* 17.2 ± 0.2
Plasma Cr (µg/dL) 61 ± 5 60 ± 8 43 ± 6* 45 ± 6*
Urine volume (ml) (24 h) 1.4 ± 0.3 1.3 ± 0.3 28.0 ± 4.7* 6.2 ± 1.8*#

All data were presented as the mean ± SEM. *p < 0.05 vs. Control. #p < 0.05 vs. DOCA-UNX.